The role of octreotide (Sandostatin) in non-growth hormone-, non-thyroid-stimulating hormone-, and non-prolactin-secreting adenomas.

@article{Warnet1992TheRO,
  title={The role of octreotide (Sandostatin) in non-growth hormone-, non-thyroid-stimulating hormone-, and non-prolactin-secreting adenomas.},
  author={Andr{\'e} Warnet},
  journal={Metabolism: clinical and experimental},
  year={1992},
  volume={41 9 Suppl 2},
  pages={59-61}
}
  • André Warnet
  • Published 1992 in Metabolism: clinical and experimental
Octreotide may act on non-growth hormone-, non-thyroid-stimulating hormone, and non-prolactin-secreting adenomas. Its efficacy was reported in some corticotropin-secreting adenomas from Nelson's syndrome and from Cushing's disease. In gonadotropin-secreting adenomas, octreotide was shown to be effective in two of eight cases. In nonfunctioning adenomas, visual improvement was observed with octreotide in 14 of 23 cases in a French multicenter study. Among the 33 patients whose tumor volume was… CONTINUE READING